期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Role of cell adhesion signal molecules in hepatocellular carcinoma cell apoptosis 被引量:15
1
作者 Jian-Min Su Li-Ying Wang +1 位作者 yu-long liang Xi-liang Zha 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第30期4667-4673,共7页
AIM: Cell adhesion molecules and their signal molecules play a very important role in carcinogenesis. The aim of this study is to elucidate the role of these molecules and the signal molecules of integrins and E-cadh... AIM: Cell adhesion molecules and their signal molecules play a very important role in carcinogenesis. The aim of this study is to elucidate the role of these molecules and the signal molecules of integrins and E-cadherins, such as (focal adhesion kinase) FAK, (integrin linked kinase) ILK, and β-catenin in hepatocellular carcinoma cell apoptosis. METHODS: We first synthesized the small molecular compound, S-(1,2-dichlorovinyl)-L-cysteine (DCVC), and identified it, by element analysis and ^1H NMR. To establish the apoptosis model of the SMMC-7721 hepatocellular carcinoma cell, we treated cells with DCVC in EBSS for different concentrations or for various length times in the presence of 20 μmol/L N,N-cliphenyl-p-phenylenediamine, which blocks necrotic cell death and identified this model by flow cytometry and DNA ladder. Then we studied the changes of FAK, ILK, β-catenin, and PKB in this apoptotic model by Western blot. RESULTS: We found that the loss or decrease of cell adhesion signal molecules is an important reason in apoptosis of SMMC-7721 hepatocellular carcinoma cell and the apoptosis of SMMC-7721 cell was preceded by the loss or decrease of FAK, ILK, PKB, and β-catenin or the damage of cell-matrix and cell-cell adhesion. CONCLUSION: Our results suggested that the decrease of adhesion signal molecules, FAK, ILK, PKB, and β-catenin, could induce hepatocellular carcinoma cell apoptosis. 展开更多
关键词 Cell adhesion signal molecule Hepatocellular carcinoma Cell apoptosis
暂未订购
Influence of Fe Addition on Phase Transformation,Microstructure and Mechanical Property of Equiatomic NiTi Shape Memory Alloy 被引量:6
2
作者 Ya-Nan Zhao Shu-Yong Jiang +1 位作者 Yan-Qiu Zhang yu-long liang 《Acta Metallurgica Sinica(English Letters)》 SCIE EI CAS CSCD 2017年第8期762-770,共9页
Based on equiatomic nickel and titanium, three kinds of NiTiFe alloys with a nominal chemical composition of Ni49Ti49Fe2, Ni48Ti48Fe4 and Ni47Ti47Fe6 (at.%), respectively, have been designed to investigate the influ... Based on equiatomic nickel and titanium, three kinds of NiTiFe alloys with a nominal chemical composition of Ni49Ti49Fe2, Ni48Ti48Fe4 and Ni47Ti47Fe6 (at.%), respectively, have been designed to investigate the influence of the addition of Fe element on phase transformation, microstructure and mechanical property of equiatomic NiTi shape memory alloy. The microstructures of three kinds of NiTiFe alloys are characterized by the equiaxed grains instead of the dendrites. Consequently, some Ti2Ni precipitates are found to distribute in the grains interior and at the grain boundaries. The content of Fe element has an important influence on mechanical property of NiTiFe alloy. With increasing content of Fe element, the strength of NiTiFe alloy increases substantially, but the plasticity decreases sharply. It can be concluded that pre- cipitation strengthening and solution strengthening play a significant role in enhancing the strength of NiTiFe alloy. In the case of three NiTiFe alloys, neither martensitic transformation nor reverse transformation can be observed in the range from -150 to 150 ~C. On the one hand, the phase transformation temperature is probably out of the scope of the present experimental temperature. On the other hand, the addition of Fe element probably suppresses first-order martensitic transformation or reverse transformation, and consequently the second-order-like phase transformation from an incom- mensurate stage to a commensurate stage can probably take place. 展开更多
关键词 Shape memory alloy Mechanical property MICROSTRUCTURE Phase transformation
原文传递
Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer 被引量:5
3
作者 Jian-Jing liang Wen-Jing Feng +2 位作者 Ru Li Run-Tao Xu yu-long liang 《World Journal of Clinical Cases》 SCIE 2023年第5期1058-1067,共10页
BACKGROUND Thyroid cancer(TC)is a common malignant tumor in the endocrine system.In recent years,the incidence and recurrence rates of TC have been raising due to increasing work pressure and irregular lifestyles.Thyr... BACKGROUND Thyroid cancer(TC)is a common malignant tumor in the endocrine system.In recent years,the incidence and recurrence rates of TC have been raising due to increasing work pressure and irregular lifestyles.Thyroid-stimulating hormone(TSH)is a specific parameter for thyroid function screening.This study aims to explore the clinical value of TSH in regulating the progression of TC,so as to find a breakthrough for the early diagnosis and treatment of TC.AIM To explore the value and safety of TSH in the clinical efficacy of patients with TC.METHODS 75 patients with TC admitted to the Department of Thyroid and Breast Surgery of our hospital from September 2019 to September 2021 were selected as the observation group,and 50 healthy subjects were selected as the control group during the same period.The control group was treated with conventional thyroid replacement therapy,and the observation group was treated with TSH suppression therapy.The soluble interleukin(IL)-2 receptor(sIL-2R),IL-17,IL-35levels,free triiodothyronine(FT3),free tetraiodothyronine(FT4),CD3+,CD4+,CD8+,CD44V6,and tumor supplied group of factor(TSGF)levels were observed in the two groups.The occurrence of adverse reactions was compared between the two groups.RESULTS After treatment with different therapies,the levels of FT3,FT4,CD3+,and CD4+in the observation group and the control group were higher than those before treatment,while the levels of CD8+,CD44V6,and TSGF were lower than those before treatment,and the differences were statistically significant(P<0.05).More importantly,the levels of sIL-2R and IL-17 in the observation group were lower than those in the control group after 4 wk of treatment,while the levels of IL-35 were higher than those in the control group,and the differences were statistically significant(P<0.05).The levels of FT3,FT4,CD3+,and CD4+in the observation group were higher than those in the control group,and the levels of CD8+,CD44V6,and TSGF were lower than those in the control group.There was no significant difference in the overall incidence rate of adverse reactions between the two groups(P>0.05).CONCLUSION TSH suppression therapy can improve the immune function of patients with TC,lower the CD44V6 and TSGF levels,and improve serum FT3 and FT4 levels.It demonstrated excellent clinical efficacy and a good safety profile. 展开更多
关键词 Thyroid-stimulating hormone Thyroid cancer Clinical efficacy Safety profile
暂未订购
A de novo frameshift mutation of the SRY gene leading to a patient with 46,XY complete gonadal dysgenesis 被引量:1
4
作者 Xiao-Bo Wang yu-long liang +6 位作者 Zi-Jue Zhu Yong Zhu Peng Li Jia-Ping Cao Qun-Ying Zhang Qiang Liu Zheng Li 《Asian Journal of Andrology》 SCIE CAS CSCD 2019年第5期522-524,共3页
Dear Editor,Sex in mammals is genetically determined and defined at the cellular level by the sex chromosome constitution(XY males and XX females)and at the phenotypic level by the development of genderspecific anatom... Dear Editor,Sex in mammals is genetically determined and defined at the cellular level by the sex chromosome constitution(XY males and XX females)and at the phenotypic level by the development of genderspecific anatomy,physiology,and behavior.146,XY complete gonadal dysgenesis(46,XY CGD),first reported by Swyer in 1955,^2 is a rare congenital condition with completely or partially disordered gonadal development,leading to discordance between the genetic,gonadal,and phenotypic sex.Affected patients have a 46,XY karyotype,a female phenotype,normal female external genitalia,and CGD("streak gonads")without sperm production and follicular or steroid function. 展开更多
关键词 46 XY ANATOMY gonadal
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部